LNTH · NASDAQ · Drug Manufacturers - Specialty & Generic

Lantheus

Commercializes PET radiodiagnostics and ultrasound-enhancing agents for prostate cancer, amyloid, and cardiac imaging.

$100.51
After-hours close−0.24 (−0.24%)
At close$100.75(+0.28%)

Breakdown13F · Form 4

Institutions 129.44%Insiders 2.00%

A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.

Shares outstanding 65.11M · Float 58.36M · 89.7% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
BlackRock, Inc.8.40M12.90%13FAug 7, 2026
Farallon Capital Management LLC5.58M8.58%13FAug 14, 2026
Jupiter Topco LLC5.19M7.97%13FAug 14, 2026
Michael G. Linn5.06M7.30%13GNov 14, 2024
Janus Henderson Group PLC4.77M7.40%13GMay 15, 2026

Institutions13F, as of Jun 30, 2026

477 holders · 84.27M shares · 98 new positions · 250 increased · 144 reduced · 39 closed

HolderShares% outstandingChg q/qFiled
BlackRock, Inc.8.40M12.90%+214.4KAug 7, 2026
Farallon Capital Management LLC5.58M8.58%0Aug 14, 2026
Jupiter Topco LLC5.19M7.97%+5.19MnewAug 14, 2026
FMR LLC3.88M5.96%−746.5KAug 13, 2026
Vanguard Portfolio Management LLC3.24M4.97%+64.2KAug 13, 2026
Vanguard Capital Management LLC2.93M4.50%+17.9KAug 13, 2026
American Century Companies Inc2.82M4.33%+1.04MAug 12, 2026
State Street Corp2.50M3.84%+70.9KAug 7, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Janus Henderson Group PLC7.40%4.77M13GMay 15, 2026
Michael G. Linnincl. Rajiv A. Patel, Thomas G. Roberts, Jr. +26 more7.30%5.06M13GNov 14, 2024
FMR LLC6.50%4.40M13GNov 5, 2025
Vanguard Capital Management5.25%3.42M13GApr 30, 2026
Vanguard Portfolio Management5.06%3.30M13GJul 31, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Farallon Partners L L C/CA10 percent owner, other: Member of a Group Owning 10%3.48M5.34%Aug 21, 2025
Mary Anne Heinodirector, officer: Executive Chair and CEO363.6K0.56%Mar 4, 2026
Brian A. Markisondirector, officer: CEO232.4K0.36%Mar 7, 2025
Robert J. Jr. Marshallofficer: CFO and Treasurer122.8K0.19%Mar 9, 2026
Daniel Niedzwieckiofficer: See Remarks117.5K0.18%Apr 21, 2026
Paul Blanchfieldofficer: President108.2K0.17%Aug 15, 2025
Sam R. Lenodirector67.2K0.10%May 18, 2026
Amanda Michelle Morganofficer: Chief Commercial Officer64.2K0.10%Mar 9, 2026
James H. Thralldirector39.9K0.06%May 18, 2026
Ludger Dinkelborgofficer: See Remarks33.2K0.05%Aug 19, 2026

2 ten-percent owners hold 3.60M shares by Form 4, outside the officers-and-directors figure above · 21 people have not refiled in the last 18 months (3.25M shares), so they are not in the figure above

Latest trades

No open-market trades in the last 12 months.

CongressHouse and Senate disclosures

Not reported.